Search results
PROMOTED
How do worsening heart events dictate the long-term outcomes of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and can earlier intervention influence the disease trajectory in ATTR-CM? In this new sub-analysis from ATTRibute-CM, recorded onsite at ESC Heart Failure Congress (HFA) 2026, Prof Marianna Fontana (University College London, London, UK) sheds further light onto these…
View more
HFA 2026: Updates on ATTR-CM
Added:
17 hours ago
Video Series
Added:
1 year ago
Added:
8 months ago
ESC Congress 2025 - Late-breaker host Dr Harriette Van Spall (McMaster University, CA) joins Prof Julie De Backer (University Hospital Ghent, BE) to discuss the newly released 2025 ESC Guidelines for the Management of Cardiovascular Disease in Pregnancy. Together, they highlight key updates, critical advances in maternal cardiovascular care, and evidence-based recommendations tailored for this…
View more
Cardiovascular Disease and Type 2 Diabetes
Added:
1 year ago
Review Article
Preterm Birth and Maternal Cardiovascular Risk
Added:
1 week ago
Review Article
Ibrutinib, Venetoclax and Adverse Cardiovascular Events
Added:
7 months ago
Expert Opinion
Frailty and Cardiovascular Risk
Added:
1 week ago
Review Article
Obesity Management and Cardiovascular Disease
Added:
1 month ago
Review Article
Cardiovascular Risk in NAFLD
Added:
2 years ago
Review Article
Added:
1 month ago
ACC.26 – Dr Michael McConnell (Stanford Health Care, Stanford, CA, US) joins us to discuss findings from a prospective, multicentre clinical trial evaluating whether artificial intelligence analysis of retinal images can identify patients at elevated atherosclerotic cardiovascular risk.Findings showed strong sensitivity and specificity in identifying those at risk of ASCVD in a diverse study…
View more